Cognition Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CGTX Key Statistics
Stock Snapshot
The current Cognition Therapeutics(CGTX) stock price is $0.70, with a market capitalization of 66.52M. The stock trades at a price-to-earnings (P/E) ratio of -3.63.
During the trading session on 2026-11-03, Cognition Therapeutics(CGTX) shares reached a daily high of $0.73 and a low of $0.67. At a current price of $0.70, the stock is +4.2% higher than the low and still -4.1% under the high.
Trading activity shows a volume of 421.55K, compared to an average daily volume of 441.22K.
The stock's 52-week range extends from a low of $0.55 to a high of $1.83.
The stock's 52-week range extends from a low of $0.55 to a high of $1.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.